Project Grant HT94252410068
Award Date
4/1/24
Completion Date
3/31/27
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Kansas City, KS 66160, USA
Similar Awards
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $766,886.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on Sep 30, 2023. The 2-year grant supports research on the importance of NKG2D signaling-induced IL-24 secretion by tumor-specific CD8+ T cells. Through this biomedical research project, KUMCRI aims to investigate medical solutions that could transform health care for Service...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $930,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 1, 2024, supports research to investigate the progression of ductal carcinoma in situ (DCIS) to invasive basal-like breast cancer, with a focus on the role of N-RAS. The research aims to advance scientific knowledge and develop innovative therapies in the...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $1,550,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "RBP-J INHIBITION AS A NOVEL LATENCY REVERSAL STRATEGY FOR HIV-1-RELATED KIDNEY DISEASES", aims to support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The funding will enable...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $250,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "The Biology of Frailty in People with Multiple Sclerosis," will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The project will run from July 1, 2025, to June 30, 2027, and aims...
This $620,000 Project Grant, awarded on June 15, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to elucidate the late effects of radiation in head and neck cancer patients. The research aims to advance scientific knowledge and develop innovative therapies in the field of cancer. As a prime federal grant recipient, KUMCRI has an extensive...
This federal Project Grant award, totaling $3,560,880, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the public. The primary awardee, the University of Kansas Medical Center Research Institute, Inc. (KUMCRI), will conduct sophisticated scientific investigations to address various medical...
This federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research at the University of Kentucky Research Foundation focused on "Targeting MNK/GRP78 Pathway to Disrupt Proteostasis Rewiring in Castration-Resistant Prostate Cancer". The $1,602,137 award, spanning from April 2025 to April 2028, aims to investigate innovative medical solutions for military personnel and the broader...
This $309,528 Project Grant was awarded by the Defense Health Agency on February 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI). The grant supports a project titled "Evaluating the Role of Somatic Mutations in Autosomal Dominant Polycystic Kidney Disease Using Single-Cell Genomics", which aims to advance scientific understanding and treatment of this condition through...
The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
The Department of Defense's Defense Health Agency awarded Duke University a $1,344,946 Project Grant on September 1, 2023 through the Military Medical Research and Development program (CFDA 12.420). This grant supports a 3-year research project titled "Understanding Heterogeneity and Improving the Precision of Prostate Cancer Clinical Outcomes in the Modern Era." The research aims to advance understanding and treatment of prostate cancer, with a focus on improving clinical outcomes for...